CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Modern Pathology

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2009.43PMID 19377443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors

  2008cited by this paper
• Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies.

  2008cited by this paper
• Guidance for fluorescence in situ hybridization testing in hematologic disorders.

  2007cited by this paper
• A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia.

  2007cited by this paper
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007cited by this paper
• Sunitinib: bridging present and future cancer treatment.

  2007cited by this paper
• Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.

  2007cited by this paper
• Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression.

  2007cited by this paper
• Sunitinib in patients with metastatic renal cell carcinoma.

  2006cited by this paper
• Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure

  2006cited by this paper
• Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

  2006cited by this paper
• Inhibition of c-fms by Imatinib: Expanding the Spectrum of Treatment

  2005cited by this paper
• Molecular classification of renal tumors by gene expression profiling.

  2005cited by this paper
• A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.

  2005cited by this paper
• Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

  2005cited by this paper
• Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop.

  2005cited by this paper
• Macrophage Colony-Stimulating Factor-1 Receptor Expression Is Associated with Poor Outcome in Breast Cancer by Large Cohort Tissue Microarray Analysis

  2004cited by this paper
• The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.

  2004cited by this paper
• The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update

  2004cited by this paper
• The genetics and genomics of cancer

  2003cited by this paper
• Aberrant Expression of HOXA9, DEK, CBL and CSF1R in Acute Myeloid Leukemia

  2003cited by this paper
• DNA extraction from tissue.

  2003cited by this paper
• Mutational analysis of class III receptor tyrosine kinases (C‐KIT, C‐FMS, FLT3) in idiopathic myelofibrosis

  2003cited by this paper
• Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression

  2002cited by this paper
• Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma.

  2002cited by this paper
• Rules for making human tumor cells.

  2002cited by this paper
• The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma.

  2001cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• Molecular Cytogenetic Analysis of 17 Renal Cancer Cell Lines: Increased Copy Number at 5q31‐33 in Cell Lines from Nonpapillary Carcinomas

  2000cited by this paper
• Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.

  1999cited by this paper
• DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.

  1998cited by this paper
• Biological consequences of a point mutation at codon 969 of the FMS gene.

  1998cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.

  1997cited by this paper
• The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

  1995cited by this paper
• Identification of the von Hippel-Lindau disease tumor suppressor gene.

  1993cited by this paper
• Expression of the macrophage colony‐stimulating factor and its receptor in gynecologic malignancies

  1991cited by this paper
• FMS mutations in myelodysplastic, leukemic, and normal subjects.

  1990cited by this paper

• A systematic in-silico functional and structural analysis reveals deleterious missense nsSNPs in the human CSF1R gene

  2025cites this paper
• CSF-1R in Cancer: More than a Myeloid Cell Receptor

  2024cites this paper
• Insights into CSF-1R Expression in the Tumor Microenvironment

  2024cites this paper
• Therapeutic advances of targeting receptor tyrosine kinases in cancer

  2024cites this paper
• Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma

  2024cites this paper
• Molecular targeted therapy for anticancer treatment

  2022cites this paper
• Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis

  2020cites this paper
• CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis

  2020cites this paper
• The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor

  2020cites this paper
• Early-life adversity programs long-term cytokine and microglia expression within the HPA axis in female Japanese quail

  2019cites this paper
• Imatinib inhibits CSF1R that stimulates proliferation of rheumatoid arthritis fibroblast‐like synoviocytes

  2018cites this paper
• Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.

  2018cites this paper
• First-inHuman Study of AMG 820 , a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody , in Patients with Advanced Solid Tumors

  2017influential citation
• An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology

  2017cites this paper
• First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors

  2017cites this paper
• Novel insights into the molecular heterogeneity of hepatocellular carcinoma Running head : HCC molecular heterogeneity

  2017cites this paper
• Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis

  2017cites this paper
• Novel insights into the molecular heterogeneity of hepatocellular carcinoma

  2017cites this paper
• CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids.

  2016cites this paper
• Differential Effects of CSF-1R D802V and KIT D816V Homologous Mutations on Receptor Tertiary Structure and Allosteric Communication

  2014cites this paper
• The biology and trafficking of the FMS receptor

  2014cites this paper
• Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.

  2014cites this paper
• Molecular Biology and Genetics

  2013cites this paper
• IL-34 and CSF-1: similarities and differences

  2013cites this paper
• Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications.

  2013cites this paper
• Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases

  2012cites this paper
• Multi-level Whole Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma

  2012cites this paper
• Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.

  2012influential citation
• Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma.

  2012cites this paper
• Title: Autocrine CSF-1 and CSF-1 Receptor Co-expression Promotes Renal Cell Carcinoma Growth Running Title: CSF-1 dependent growth of renal carcinoma

  2011influential citation
• Mutations in the colony stimulating factor 1 receptor (CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids

  2011cites this paper